检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Teclistamab versus Belgian real-world clinical practice in triple-class exposed relapsed and refractory multiple myeloma patients using adjusted comparison

Michel Delforge,Sebastien Anguille,Julien Depaus,Nathalie Meuleman,Ann Van De Velde,Isabelle Vande Broek,Joris Diels,Nichola Erler-Yates,Sebastien Van Causenbroeck,Kirsten Van Nimwegen, Sophie Vandervennet,Susanne Lub,Marie-Christiane Madeleine Vekemans

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）

引用 0|浏览8
暂无评分
关键词
refractory multiple myeloma patients,real-world,triple-class
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要